36 min listen
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
ratings:
Length:
59 minutes
Released:
Mar 27, 2023
Format:
Podcast episode
Description
The more we learn about inflammation and the complex cause/contributor/symptom roles it plays in various disease states, the more business activity we see in the inflammation therapeutics space. But to date, commercial pharmaceutical and biologic efforts have fallen short for patients, says Moonlake Immunotherapeutics CEO Jorge Santos Da Silva, Ph.D. What's the problem, and why does he think his camelid-derived nanobody candidates are poised to outperform big-pharma standards from the likes of UCB and Novartis? Find out on this week's episode of the Business of Biotech. Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!
Released:
Mar 27, 2023
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform by Business Of Biotech